News Headlines Article

Beyond Hillary and Bernie, drug pricing at front of another campaign
San Francisco Business Times

Democratic presidential hopefuls Hillary Clinton and Bernie Sanders have tapped into the populist issue of drug pricing. Now, so has an East Bay drug company in its campaign to turn back an unwanted $2 billion offer. In a statement Thursday, Depomed Inc. (NASDAQ: DEPO) of Newark said specialty drug price hikes by suitor Horizon Pharma plc (NASDAQ: HZNP) raises concerns about that company’s business model.